Kane Biotech Inc Ord (KNBIF) Q1 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, and thank you for standing by. Welcome to Cain Biotech's first quarter 2023 earnings conference call. During today's presentation, all parties will be in a listen-only mode. Following the presentation, the conference call will be open to questions. If you have a question, simply press star 1-1 on your telephone. If you would like to withdraw your question, simply press star 1-1 again. This conference is being recorded today, May 25, 2023. I would now like to turn the conference call over to Nicole Cain Biotech's investor relations advisor. Please go ahead. Thank you, operator. Good afternoon and welcome everyone to Cain Biotech's quarterly earnings conference call. We are delighted to have you join us today. This call will cover Cain's financial and operating results for the first quarter of 2023 along with a discussion of some of our recent highlights and goals for 2023 and beyond. Following our prepared remarks, we will open the conference call to a question and answer period. Our call today will be led by Cane's Chief Executive Officer, Mark Edwards. Before we begin our formal remarks, I would like to remind everyone that some of the statements on this conference call contain certain forward-looking information and statements within the meaning of securities law, which may not be based on historical fact, including without limitation, Statements containing the words believe, should, may, plan, will, estimate, predict, continue, anticipate, potential, intends, expects, or other similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, events, or developments to be materially different from any future results, events, or developments expressed or implied b...